Publicaciones en colaboración con investigadores/as de Pierre and Marie Curie University (10)

2022

  1. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens

    AIDS (London, England), Vol. 36, Núm. 15, pp. 2107-2119

2020

  1. Addition of maraviroc versus placebo to standard antiretroviral therapy for initial treatment of advanced HIV infection: A randomized trial

    Annals of Internal Medicine, Vol. 172, Núm. 5, pp. 297-305

  2. Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study

    Annals of Intensive Care, Vol. 10, Núm. 1

2019

  1. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

    Antiviral Research, Vol. 170

2018

  1. Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit (Intensive Care Medicine, (2018), 44, 7, (1027-1038), 10.1007/s00134-018-5196-7)

    Intensive Care Medicine

  2. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit

    Intensive Care Medicine, Vol. 44, Núm. 7, pp. 1027-1038

2017

  1. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)

    Intensive Care Medicine, Vol. 43, Núm. 12, pp. 1820-1828

2015

  1. A Multifaceted Intervention Designed to Improve Medical Management of Moderate to Advanced Chronic Kidney Disease in HIV-Infected Patients: A Cluster Randomized Trial

    Clinical Infectious Diseases, Vol. 61, Núm. 3, pp. 375-384

  2. Is impact of statin therapy on all-cause mortality different in HIV-infected individuals compared to general population? Results from the FHDH-ANRS CO4 cohort

    PLoS ONE, Vol. 10, Núm. 7

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473